Free Trial

Rigel Pharmaceuticals (RIGL) Short Interest Ratio & Short Volume

$10.35
-0.90 (-8.00%)
(As of 07/17/2024 ET)

Rigel Pharmaceuticals Short Interest Data

Current Short Interest
648,200 shares
Previous Short Interest
4,900,000 shares
Change Vs. Previous Month
-86.77%
Dollar Volume Sold Short
$5.33 million
Short Interest Ratio
3.1 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
17,560,000 shares
Float Size
17,210,000 shares
Short Percent of Float
3.77%
Today's Trading Volume
115,273 shares
Average Trading Volume
159,813 shares
Today's Volume Vs. Average
72%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Rigel Pharmaceuticals ?

Sign up to receive the latest short interest report for Rigel Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RIGL Short Interest Over Time

RIGL Days to Cover Over Time

RIGL Percentage of Float Shorted Over Time

Rigel Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2024648,200 shares $5.33 million -86.8%3.8%3.1 $8.22
6/15/20244,900,000 shares $46.70 million -7.2%N/A3.2 $9.53
5/31/20245,280,000 shares $5.16 million -6.4%N/A3.6 $0.98
5/15/20245,640,000 shares $5.47 million -0.5%N/A3.7 $0.97
4/30/20245,670,000 shares $5.95 million +9.7%N/A3.8 $1.05
4/15/20245,170,000 shares $5.95 million +3.2%N/A3.7 $1.15
3/31/20245,010,000 shares $7.41 million +1.4%N/A4 $1.48
3/15/20244,940,000 shares $6.72 million +32.1%N/A4.5 $1.36
2/29/20243,740,000 shares $5.68 million +6.9%N/A3.5 $1.52
2/15/20243,500,000 shares $4.27 million +2.3%N/A3.1 $1.22
1/31/20243,420,000 shares $4.00 million No ChangeN/A3.3 $1.17
1/15/20243,420,000 shares $4.55 million -5.3%N/A2.8 $1.33
12/31/20233,610,000 shares $5.23 million -0.6%N/A3 $1.45
12/15/20233,630,000 shares $4.68 million -4.0%N/A3.1 $1.29
11/30/20233,780,000 shares $4.31 million -1.3%N/A3.2 $1.14
11/15/20233,830,000 shares $3.04 million +5.5%N/A4 $0.79
10/31/20233,630,000 shares $2.93 million -4.0%N/A3.5 $0.81
10/15/20233,780,000 shares $3.55 million +1.9%N/A3.3 $0.94
9/30/20233,710,000 shares $4.01 million +3.6%N/A3.7 $1.08
9/15/20233,580,000 shares $4.08 million -6.3%N/A3.1 $1.14
8/31/20233,820,000 shares $4.35 million +2.7%N/A3.1 $1.14
8/15/20233,720,000 shares $4.39 million -7.7%N/A2.5 $1.18
7/31/20234,030,000 shares $5.56 million +4.7%N/A2 $1.38
7/15/20233,850,000 shares $4.85 million +0.5%N/A1.8 $1.26
6/30/20233,830,000 shares $4.94 million -39.7%N/A1.8 $1.29
6/15/20236,350,000 shares $10.48 million -15.5%N/A2.8 $1.65
5/31/20237,510,000 shares $10.51 million -7.3%N/A2.9 $1.40
5/15/20238,100,000 shares $10.85 million -4.8%N/A2.6 $1.34
4/30/20238,510,000 shares $9.62 million +0.5%N/A3.2 $1.13
4/15/20238,470,000 shares $10.42 million +1.6%N/A2.9 $1.23
3/31/20238,340,000 shares $11.01 million -1.1%N/A2.7 $1.32
3/15/20238,430,000 shares $14.16 million +10.2%N/A2.6 $1.68
2/28/20237,650,000 shares $11.55 million +12.5%N/A2 $1.51
2/15/20236,800,000 shares $11.02 million +13.7%N/A1.6 $1.62
1/31/20235,980,000 shares $9.81 million +6.0%N/A1.5 $1.64
1/15/20235,640,000 shares $9.98 million +5.0%N/A1.5 $1.77
12/30/20225,370,000 shares $8.06 million -15.8%N/A1.4 $1.50
12/15/20226,380,000 shares $8.10 million +57.5%N/A1.8 $1.27
11/30/20224,050,000 shares $2.72 million -26.5%N/A1 $0.67
11/15/20225,510,000 shares $4.14 million -7.6%N/A2 $0.75
Human testing is the last step before this company goes big (Ad)

Biotech innovations have the potential to change the world. And help you build wealth in the process.

You can learn more about it here.
10/31/20225,960,000 shares $4.34 million -16.9%N/A1.9 $0.73
10/15/20227,170,000 shares $5.82 million -6.0%N/A2 $0.81
9/30/20227,630,000 shares $9.00 million -30.3%N/A2 $1.18
9/15/202210,950,000 shares $14.45 million +16.2%N/A2.6 $1.32
8/31/20229,420,000 shares $13.38 million +0.3%N/A1.6 $1.42
8/15/20229,390,000 shares $14.65 million -6.4%N/A1.4 $1.56
7/31/202210,030,000 shares $11.94 million -4.0%6.3%1.6 $1.19
7/15/202210,450,000 shares $13.69 million -9.5%6.6%1.8 $1.31
6/30/202211,550,000 shares $13.05 million +62.2%7.2%2.1 $1.13
6/15/20227,120,000 shares $5.80 million +1.9%4.5%1.4 $0.81
5/31/20226,990,000 shares $12.65 million +4.5%N/A2 $1.81
5/15/20226,690,000 shares $13.11 million +0.9%N/A3.4 $1.96
4/30/20226,630,000 shares $15.65 million -24.5%N/A3.5 $2.36
4/15/20228,780,000 shares $26.08 million -12.1%N/A4.6 $2.97
3/31/20229,990,000 shares $29.87 million -22.3%N/A5.1 $2.99
3/15/202212,850,000 shares $37.14 million -10.8%N/A6.6 $2.89
2/28/202214,410,000 shares $36.17 million +3.2%8.5%8.1 $2.51
2/15/202213,960,000 shares $36.44 million -11.1%8.2%8.5 $2.61
1/31/202215,710,000 shares $40.22 million +1.5%9.2%9.4 $2.56
1/15/202215,480,000 shares $37.46 million +5.0%N/A9.4 $2.42
12/31/202114,750,000 shares $39.09 million -4.2%N/A9.7 $2.65
12/15/202115,390,000 shares $38.32 million +2.1%N/A10.8 $2.49
11/30/202115,070,000 shares $40.24 million -6.4%N/A11.2 $2.67
11/15/202116,100,000 shares $49.11 million -6.3%N/A12.2 $3.05
10/29/202117,180,000 shares $57.72 million +0.2%N/A13.1 $3.36
10/15/202117,140,000 shares $57.93 million -0.1%N/A12.2 $3.38
9/30/202117,160,000 shares $62.29 million -8.0%N/A12.2 $3.63
9/15/202118,660,000 shares $71.65 million -3.9%N/A12.4 $3.84
8/31/202119,410,000 shares $73.76 million -6.6%N/A11.7 $3.80
8/13/202120,780,000 shares $77.30 million +0.2%N/A11.7 $3.72
7/30/202120,730,000 shares $82.92 million -0.5%N/A10.6 $4.00
7/15/202120,830,000 shares $85.19 million -3.6%12.3%10.7 $4.09
6/30/202121,600,000 shares $93.74 million -11.0%12.7%8.6 $4.34
6/15/202124,280,000 shares $103.43 million +3.5%14.3%9.3 $4.26
5/28/202123,460,000 shares $87.27 million -1.9%13.8%8.9 $3.72
5/14/202123,920,000 shares $86.59 million +6.4%N/A7.8 $3.62
4/30/202122,480,000 shares $83.18 million -3.7%N/A6.2 $3.70
4/15/202123,340,000 shares $87.06 million +6.0%N/A5.8 $3.73
3/31/202122,030,000 shares $74.90 million +30.6%N/A5.9 $3.40
3/15/202116,870,000 shares $71.36 million +0.4%N/A4.4 $4.23
2/26/202116,810,000 shares $69.59 million -13.2%N/A4.4 $4.14
2/12/202119,360,000 shares $87.89 million -7.7%N/A5.6 $4.54
1/29/202120,970,000 shares $72.98 million -1.8%N/A7.2 $3.48
1/15/202121,360,000 shares $81.38 million -1.3%N/A8.4 $3.81
12/31/202021,650,000 shares $78.37 million -4.2%N/A9 $3.62
12/15/202022,600,000 shares $73.79 million -0.8%N/A9.3 $3.27
11/30/202022,780,000 shares $70.85 million -2.9%N/A9 $3.11
11/15/202023,460,000 shares $64.52 million -3.9%N/A9.1 $2.75
10/30/202024,420,000 shares $61.54 million +18.0%N/A9.1 $2.52
10/15/202020,700,000 shares $54.44 million +6.4%12.6%6.7 $2.63
Human testing is the last step before this company goes big (Ad)

Biotech innovations have the potential to change the world. And help you build wealth in the process.

You can learn more about it here.
9/30/202019,460,000 shares $46.70 million +96.0%11.8%2.4 $2.40
9/15/20209,930,000 shares $24.53 million +0.4%6.0%1.2 $2.47
8/31/20209,890,000 shares $24.63 million -0.3%6.0%1.3 $2.49
8/14/20209,920,000 shares $24.11 million +15.8%6.0%1.3 $2.43
7/31/20208,570,000 shares $19.71 million -44.1%5.2%1.1 $2.30
7/15/202015,320,000 shares $50.25 million +0.9%9.4%2.2 $3.28
6/30/202015,190,000 shares $27.34 million +3.9%9.3%8.3 $1.80
6/15/202014,620,000 shares $27.19 million -0.5%9.0%8.9 $1.86
5/29/202014,700,000 shares $29.84 million -0.3%9.0%9.6 $2.03
5/15/202014,740,000 shares $26.02 million +1.2%9.0%9.6 $1.77
4/30/202014,560,000 shares $26.50 million -4.6%8.8%10 $1.82
4/15/202015,260,000 shares $25.48 million +0.6%9.3%11.2 $1.67
3/31/202015,170,000 shares $23.67 million -0.4%9.2%10 $1.56
3/13/202015,229,200 shares $26.96 million -0.9%9.2%10.7 $1.77
2/28/202015,370,000 shares $21.98 million -1.8%9.3%9.9 $1.43
2/14/202015,650,000 shares $31.30 million +2.3%9.6%10.1 $2.00
1/31/202015,300,000 shares $33.20 million +42.6%9.3%9.7 $2.17
1/15/202010,730,000 shares $24.68 million -3.1%6.6%6.5 $2.30
12/31/201911,070,000 shares $27.90 million -6.5%6.8%7.3 $2.52

RIGL Short Interest - Frequently Asked Questions

What is Rigel Pharmaceuticals' current short interest?

Short interest is the volume of Rigel Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 648,200 shares of RIGL short. 3.77% of Rigel Pharmaceuticals' shares are currently sold short. Learn More on Rigel Pharmaceuticals' current short interest.

What is a good short interest ratio for Rigel Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RIGL shares currently have a short interest ratio of 3.0. Learn More on Rigel Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Rigel Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.77% of Rigel Pharmaceuticals' floating shares are currently sold short.

Is Rigel Pharmaceuticals' short interest increasing or decreasing?

Rigel Pharmaceuticals saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 648,200 shares, a decrease of 86.8% from the previous total of 4,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Rigel Pharmaceuticals' float size?

Rigel Pharmaceuticals currently has issued a total of 17,560,000 shares. Some of Rigel Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Rigel Pharmaceuticals currently has a public float of 17,210,000 shares.

How does Rigel Pharmaceuticals' short interest compare to its competitors?

3.77% of Rigel Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Rigel Pharmaceuticals: G1 Therapeutics, Inc. (10.88%), Avid Bioservices, Inc. (19.44%), Emergent BioSolutions Inc. (10.34%), Lexicon Pharmaceuticals, Inc. (8.20%), Vanda Pharmaceuticals Inc. (5.19%), Agenus Inc. (11.84%), XOMA Co. (2.08%), Codexis, Inc. (2.98%), Achieve Life Sciences, Inc. (4.43%), Regulus Therapeutics Inc. (10.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Rigel Pharmaceuticals stock?

Short selling RIGL is an investing strategy that aims to generate trading profit from Rigel Pharmaceuticals as its price is falling. RIGL shares are trading down $0.81 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Rigel Pharmaceuticals?

A short squeeze for Rigel Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RIGL, which in turn drives the price of the stock up even further.

How often is Rigel Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RIGL, twice per month. The most recent reporting period available is June, 30 2024.



This page (NASDAQ:RIGL) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners